THROMBITENE
King Pharmaceuticals Research And Development, Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78243654 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Attorney Name | Linda M. Buckley (Reg. No. 31,003) |
| Attorney Docket Number | 46453/57585- |
| Law Office Assigned | M60 |
| Employee Name | EDWARDS, ALICIA COLLIN |
Timeline
| 2003-04-30 | Application Filed |
| 2005-05-10 | Published for Opposition |
| 2005-08-02 | Location: INTENT TO USE SECTION |
| 2006-02-03 | Abandon |
| 2006-02-03 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. |
| Address | 501 FIFTH STREET BRISTOL DE 37620 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical hemostatic agents to control bleeding |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 2003-09-30 | 1 DOCK D:Assigned to Examiner |
| LETTER OF SUSPENSION E-MAILED | 2003-09-30 | 2 GNSL F:First Action |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2004-02-18 | 3 TCCA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2004-02-18 | 4 TCCA I:Incoming Correspondence |
| PAPER RECEIVED | 2004-06-09 | 5 MAIL I:Incoming Correspondence |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2004-12-08 | 6 RCCK S: |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2005-01-12 | 7 CNSA P: |
| ASSIGNED TO LIE | 2005-01-24 | 8 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2005-01-26 | 9 PREV O:Outgoing Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2005-02-23 | 10 TCCA I:Incoming Correspondence |
| NOTICE OF PUBLICATION | 2005-04-20 | 11 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2005-05-10 | 12 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2005-08-02 | 13 NOAM O:Outgoing Correspondence |
| ABANDONMENT - NO USE STATEMENT FILED | 2006-04-06 | 14 ABN6 S: |
| ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2006-04-06 | 15 MAB6 O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 THROMBITENE 78243654 not registered Dead/Abandoned |
KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. 2003-04-30 |
 THROMBITENE 75815758 not registered Dead/Abandoned |
Jones Pharma Incorporated 1999-10-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 